Literature DB >> 16971259

Alcoholic hepatitis.

David A Sass1, Obaid S Shaikh.   

Abstract

Alcoholic hepatitis is a form of hepatic injury that carries a significant morbidity and mortality. The clinical presentation is that of fatigue, malaise, and jaundice in individuals who have abused excessive quantities of alcohol. Severity at presentation, traditionally calculated using the Maddrey Discriminant Function, determines outcome; the short-term mortality can be exceptionally high, with many persons dying within 1 month of hospitalization. This article summarizes the epidemiology, pathogenesis, pathology, and clinical features of alcoholic hepatitis. Prognostic scoring systems and therapeutic options receive special emphasis.

Entities:  

Mesh:

Year:  2006        PMID: 16971259     DOI: 10.1016/j.cld.2006.05.011

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  5 in total

1.  Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).

Authors:  Sandeep Singh Sidhu; Omesh Goyal; Preeti Singla; Dinesh Gupta; Ajit Sood; Rajoo Singh Chhina; Ravinder Kumar Soni
Journal:  Dig Dis Sci       Date:  2012-03-03       Impact factor: 3.199

Review 2.  Pathogenesis of alcoholic liver disease: the role of nuclear receptors.

Authors:  Maxwell Afari Gyamfi; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2010-05

Review 3.  Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.

Authors:  Maziyar Amini; Bruce A Runyon
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

Review 4.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

5.  Severe Alcoholic Hepatitis Effectively Treated with Vitamin E as an Add-on to Corticosteroids.

Authors:  Yuichi Miyashima; Michihiko Shibata; Yuichi Honma; Hidehiko Matsuoka; Masaaki Hiura; Shintaro Abe; Masaru Harada
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.